This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Petrosino, J. F.
Right arrow Articles by Rosenberg, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Petrosino, J. F.
Right arrow Articles by Rosenberg, S. M.
Right arrowPubmed/NCBI databases
*Substance via MeSH

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, May 2002, p. 1535-1539, Vol. 46, No. 5
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.5.1535-1539.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Chromosomal System for Studying AmpC-Mediated ß-Lactam Resistance Mutation in Escherichia coli

Joseph F. Petrosino,1* Amanda R. Pendleton,1,{dagger} Joel H. Weiner,2 and Susan M. Rosenberg1,3,4*

Departments of Molecular and Human Genetics,1 Biochemistry and Molecular Biology,3 Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas 77030-3411,4 Department of Biochemistry, University of Alberta, Edmonton, Alberta T6G 2H7 Canada2

Received 5 September 2001/ Returned for modification 25 November 2001/ Accepted 9 February 2002


arrow
ABSTRACT
 
In some enterobacterial pathogens, but not in Escherichia coli, loss-of-function mutations in the ampD gene are a common route to ß-lactam antibiotic resistance. We constructed an assay system for studying mechanism(s) of enterobacterial ampD mutation using the well-developed genetics of E. coli. We integrated the Enterobacter ampRC genes into the E. coli chromosome. These cells acquire spontaneous recombination- and SOS response-independent ß-lactam resistance mutations in ampD. This chromosomal system is useful for studying mutation mechanisms that promote antibiotic resistance.


arrow
TEXT
 
Mutation is a primary cause of bacterial resistance to antibiotics. Some mutations promote resistance directly (e.g., quinolone resistance mutations in genes encoding its Escherichia coli targets, gyrA and gyrB [16]). Other chromosomal mutations can cause mutator phenotypes that increase the likelihood of acquiring a resistance mutation (42). Mutations also ameliorate the otherwise deleterious effects on cell growth and physiology of some antibiotic resistance-conferring mutations (22). Although antibiotic resistance has been studied intensively, the mechanisms that generate resistance mutations are poorly understood.

In addition to spontaneous mutation in exponentially growing cells (growth-dependent mutation), other mutation mechanisms exist that may pertain to antibiotic resistance (34, 36, 37). For example, factors such as antibiotic concentration (23), environmental conditions (12), or other stress-inducing phenomena (1, 34, 36) may enhance or repress mutational machinery that leads to resistance mutations (for a review, see reference 31). Some mutation mechanisms or factors may be more important when the organism is under suboptimal growth conditions, as is probably the case during certain stages of an infection. In this study, we utilize a relatively well-described ß-lactam resistance pathway as a model system to begin dissecting the mechanism(s) of antibiotic resistance mutation using the tools of E. coli genetics.

Chromosomally encoded AmpC ß-lactamases confer ß-lactam antibiotic resistance in many pathogenic and opportunistic bacteria and are ubiquitous in enterobacteria, except for the salmonellae, klebsiellae, Proteus mirabilis, Shigella flexneri, and Shigella dysenteriae (30, 32). Their expression is inducible in all but E. coli and the shigellae (30). In inducible strains, ampC transcription is controlled by the transcriptional activator AmpR (2). AmpR activity is regulated allosterically by two cell wall components, 1,6-anhydromuropeptide and UDP-N-acetylmuramic acid-pentapeptide (UDP-MurNAc-pentapeptide). The first allows, and the second blocks, AmpR transcriptional activator activity at ampC (19). AmpD converts (activator-promoting) 1,6-anhydromuropeptide to (activator-blocking) UDP-MurNAc-pentapeptide, which then binds AmpR and blocks ampC transcription. Thus, loss-of-function mutations in ampD cause 1,6-anhydromuropeptide accumulation and constitutively induced AmpC ß-lactamase production (7, 20, 21, 27). ampD missense and nonsense mutations are common in AmpC-mediated, ß-lactam-resistant clinical isolates (25, 38). Also, some ß-lactam antibiotics can induce expression of ampC by causing an increase in the cytoplasmic concentration of 1,6-anhydromuropeptide (7, 30).

E. coli lacks ampR, and low-level ampC expression results from a promoter embedded in the overlapping fumarate reductase (frdABCD) operon (13). High-level ß-lactam resistance, mediated by ampD loss-of-function mutation, can be reconstituted in E. coli when the ampR and ampC genes of other enterobacteria are expressed from a plasmid (28, 35). We have integrated the ampRC genes from Enterobacter cloacae into the E. coli chromosome to assay ampD mutation, as selected by its ß-lactam resistance phenotype. Background resistance imparted by the native ampC gene does not interfere with assays involving the reconstituted system. Integrating the ampRC genes into the chromosome improves upon previous plasmid-based ampRC expression systems by allowing genetic analyses not possible previously, first, because many mutant alleles used to study DNA repair, recombination, and mutation cause plasmid instability (e.g., reference 6). Second, the single-copy ampRC locus more closely models the situation in clinically relevant enterobacterial resistance (30). Third, this chromosomal system excludes mutations that confer ß-lactam resistance by increasing plasmid (and, therefore, ampC) copy number.

An ampRC expression cassette in the E. coli chromosome was constructed as follows. The strains and plasmids used are shown in Table 1. SMR5222, an E. coli strain carrying the E. cloacae ampRC+ genes in the E. coli chromosome, was constructed using the TGV (transgenic vector) system for integrating linear DNA cassettes into the E. coli chromosome (14). E. cloacae strain MHN1 ampRC+ genes were isolated from plasmid pEc1c (35) by digestion with BamHI and SalI and were ligated into BglII- and XhoI-digested pTGV-light (14) plasmid DNA, creating pJP2. pJP2 was digested with NdeI to generate an ampRC+ fragment flanked on both sides by homology to the E. coli attachment site for phage {lambda} (att{lambda}) for linear transformation in the TGV system (14). SMR5201, a transformant carrying ampRC+ replacing att{lambda} (confirmed by PCR as described elsewhere [14]) was used as a P1 donor to move att{lambda}::ampRC+ into SMR5156 by P1 transduction (as described elsewhere [14]) to create SMR5222. Subsequent strains are isogenic to SMR5222 and were created using standard phage P1 transduction (referenced elsewhere [14]), and the constructions are outlined in Table 1.


View this table:
[in this window]
[in a new window]
  		TABLE 1. E. coli strains and plasmids

We used the chromosome-based ampRC expression system to determine rates of spontaneous (growth-dependent) ampicillin resistance (Ampr) mutation in otherwise isogenic strains lacking various recombination and SOS genes. Growth-dependent mutation rates were measured in 15 tube fluctuation tests. Fifteen independent cultures for each strain were grown to saturation in 5 or 10 ml of Mueller-Hinton (MH) broth (Difco), shaking at 37°C. Cultures were diluted 10-fold, and 50 µl was plated in duplicate on MH agar plates containing 100 µg/ml ampicillin. The plates were incubated overnight at 37°C, and Ampr colonies were counted. Viable cell counts of the saturated cultures were from dilutions plated on MH incubated overnight at 37°C. Mutation rates were calculated by the method of the median (26).

The recombination and SOS genes examined—recA, recG, recA recG, lexA3(Ind-), sulA, and sulA lexA(Def)—are not required for most growth-dependent mutation; however, they are required for a mechanism of mutation observed under growth-limiting conditions of carbon starvation (for a review, see reference 37; see also references 41 and 43). Moreover, the SOS response controls several mutation-promoting proteins (40) whose possible involvement in ß-lactam resistance mutation we wished to test. The ß-lactam resistance mutation rate in recombination- and SOS-proficient (rec+) cells is about 1.4 x 10-7 cell-1 generation-1 (Table 2). The strains tested displayed only small differences in growth-dependent mutation rates, indicating that recombination and SOS genes are not important for most growth-dependent ß-lactam resistance mutation (Table 2).


View this table:
[in this window]
[in a new window]
  		TABLE 2. Rates of ß-lactam resistance mutation in E. coli DNA repair-deficient mutants

The following experiments demonstrated that the ß-lactam resistance mutations are in ampD. Based on prior observations in an E. coli model and in clinical isolates of enterobacterial pathogens (7, 27), we expected most of the ß-lactam resistance mutations to be in ampD. To test this, 20 independent ampicillin resistant mutants (each from a separate independent culture) from the rec+ and recA fluctuation test experiments were examined further. ß-Lactam sensitivity was restored to each of the 40 mutants by transforming each with pJP19 (Table 1) carrying the ampD+ gene. This complementation test shows that the ampicillin resistance mutations of the 40 independent mutants are recessive, loss-of-function mutations in ampD.

We determined the ampD sequences for each of the 40 mutants. Little difference was found between the rec+ and recA backgrounds (Fig. 1), suggesting similar mutation mechanism(s) in each. Many different mutations and insertions in ampD conferred AmpC-mediated ß-lactam resistance.



View larger version (37K):
[in this window]
[in a new window]
  		FIG. 1. Location of ampD mutations. Forty independent Ampr mutants (20 from rec+ strain SMR5222 and 20 from recA strain SMR5225) were screened for ampD mutations by complementation to ß-lactam sensitivity using pJP19 (Table 1). Apparent ampD mutations were sequenced (Lone Star Labs, Houston, Tex.) from PCR products using primers AmpD no. 3, 5'-GCGCGTCTCCGCTCACTGTTT-3'; and AmpD no. 4, 5'-GCATGCCATGCACGTTTATCG-3'. The PCR products were generated with primers AmpD no. 1 and AmpD no. 2 (legend to Table 1). The E. coli ampD sequence is given, along with 32 bp upstream of the ATG start codon. Mutations found in rec+ mutants are indicated above, and mutations found in recA mutants are shown below, the sequence. IS, insertion sequence.

Among the eight substitution mutations identified here, two were identified previously from ß-lactam resistant isolates. A Trp7Gly substitution in AmpD occurred in both the rec+ and recA strains (Fig. 2) and previously in E. coli ampicillin-resistant mutants of cells expressing the E. cloacae ampRC genes from a plasmid (18). Also, we found Asp164Glu and Asp164Ala in both rec+ and recA. Asp164Glu was found previously in Citrobacter freundii (39). Both previous ampD mutations were shown to cause full derepression of ampC, as ampD-null mutations do (28, 39).



View larger version (85K):
[in this window]
[in a new window]
  		FIG. 2. Amino acid substitutions, insertions, and deletions identified in the rec+ and recA mutants aligned with the ampD genes from nine enterobacteria. Also included are previously identified ampD mutant proteins from other laboratories (10, 18, 24, 28). rec+ mutations are in black, recA mutations are in red, and previously identified mutations are in blue. Insertions are indicated by a plus sign (+), deletions are indicated by a delta ({Delta}), and nonsense mutations are indicated by an asterisk (*). Mutations isolated multiple times show the number of times that each was encountered for each strain (rec+ or recA). Abbreviations: S. typh, Salmonella enterica serovar Typhimurium; C. freu, C. freundii; E. cloa, E. cloacae; V. chol, Vibrio cholerae; P. aeru, Pseudomonas aeruginosa; A. vine, Azotobacter vinelandii; A. acti, Actinobacillus actinomycetemcomitans; and R. sola, Ralstonia solanacearum. Alignment was performed using ClustalW (17) and formatted using BOXSHADE.

Other ampD substitution mutations found include Ser37Arg, Arg80His, Gly82Cys, Ala94Val, and Leu117Arg (Fig. 2). Although these might or might not inactivate ampD fully, substitutions that alter or abolish AmpD function reveal amino acids that are important for AmpD structure and/or function. Conservative substitutions, such as Ala94Val or Asp164Glu, highlight the specific steric and/or chemical requirements of the wild-type amino acids. For example, the intolerance for Ala94Val suggests that the smaller size of alanine is important here, because both amino acids are similarly hydrophobic. The Asp164Glu substitution involves similar charges, suggesting that this amino acid position makes important catalytic or structural contacts disrupted by the larger glutamic acid side chain. Asp164 is probably not simply a surface amino acid, because it has a seemingly stringent size requirement and because alanine at this position is also not tolerated.

Alignments show that ampD is highly conserved among various bacteria (e.g., Fig. 2). Asp164, Ala94, and the other substituted amino acids from our mutation studies are highly conserved among the aligned ampD sequences (Fig. 2) and further highlight their potential structural and/or functional importance.

The variety of loss-of-function mutations observed in this system suggests its utility for studying many kinds of mutation mechanisms. This system may be useful additionally for studying the forward mutation spectra caused by potential damaging agents and environmental factors, because mutations in the small ampD gene are easily selected and sequenced.


arrow
ACKNOWLEDGMENTS
 
We thank Mellanie Price for excellent technical support and Mary-Jane Lombardo, P. J. Hastings, Gregory McKenzie, Megan Hersh, Jeanine Pennington, and Rebecca Ponder for critical comments on the manuscript.

This work was supported by a Department of Defense Breast Cancer Research Postdoctoral Fellowship (to J.F.P.) and National Institutes of Health Grant R01-AI43917.


arrow
FOOTNOTES
 
* Corresponding authors. Mailing address: Department of Molecular and Human Genetics, Baylor College of Medicine, Room S809A, Mail Stop BCM225, One Baylor Plaza, Houston, TX 77030-3411. Phone: (713) 798-6693. Fax: (713) 798-8967. E-mail for Joseph F. Petrosino: jp691032{at}bcm.tmc.edu. E-mail for Susan M. Rosenberg: smr{at}bcm.tmc.edu. Back

{dagger} Present address: Department of Cell Biology, Johns Hopkins School of Medicine, Baltimore, MD 21205. Back


arrow
REFERENCES
 
    1
  1. Alonso, A., E. Campanario, and J. L. Martinez. 1999. Emergence of multidrug-resistant mutants is increased under antibiotic selective pressure in Pseudomonas aeruginosa. Microbiology 145:2857-2862.[Abstract/Free Full Text]
    2. 2
  2. Bartowsky, E., and S. Normark. 1991. Purification and mutant analysis of Citrobacter freundii AmpR, the regulator for chromosomal AmpC beta-lactamase. Mol. Microbiol. 5:1715-1725.[Medline]
    3. 3
  3. Blattner, F. R., G. Plunkett III, C. A. Bloch, N. T. Perna, V. Burland, M. Riley, J. Collado-Vides, J. D. Glassner, C. K. Rode, G. F. Mayhew, J. Gregor, N. W. Davis, H. A. Kirkpatrick, M. A. Goeden, D. J. Rose, B. Mau, and Y. Shao. 1997. The complete genome sequence of Escherichia coli K-12. Science 277:1453-1474.[Abstract/Free Full Text]
    4. 4
  4. Cairns, J., and P. L. Foster. 1991. Adaptive reversion of a frameshift mutation in Escherichia coli. Genetics 128:695-701.[Abstract]
    5. 5
  5. Chang, A. C., and S. N. Cohen. 1978. Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid. J. Bacteriol. 134:1141-1156.[Abstract/Free Full Text]
    6. 6
  6. Cohen, A., and A. J. Clark. 1986. Synthesis of linear plasmid multimers in Escherichia coli K-12. J. Bacteriol. 167:327-335.[Abstract/Free Full Text]
    7. 7
  7. Dietz, H., D. Pfeifle, and B. Wiedemann. 1997. The signal molecule for ß-lactamase induction in Enterobacter cloacae is the anhydromuramyl-pentapeptide. Antimicrob. Agents Chemother. 41:2113-2120.[Abstract]
    8. 8
  8. Dri, A. M., J. Rouviere-Yaniv, and P. L. Moreau. 1991. Inhibition of cell division in hupA hupB mutant bacteria lacking HU protein. J. Bacteriol. 173:2852-2863.[Abstract/Free Full Text]
    9. 9
  9. Dutreix, M., P. L. Moreau, A. Bailone, F. Galibert, J. R. Battista, G. C. Walker, and R. Devoret. 1989. New recA mutations that dissociate the various RecA protein activities in Escherichia coli provide evidence for an additional role for RecA protein in UV mutagenesis. J. Bacteriol. 171:2415-2423.[Abstract/Free Full Text]
    10. 10
  10. Ehrhardt, A. F., C. C. Sanders, J. R. Romero, and J. S. Leser. 1996. Sequencing and analysis of four new Enterobacter ampD alleles. Antimicrob. Agents Chemother. 40:1953-1956.[Abstract]
    11. 11
  11. Foster, P. L., J. M. Trimarchi, and R. A. Maurer. 1996. Two enzymes, both of which process recombination intermediates, have opposite effects on adaptive mutation in Escherichia coli. Genetics 142:25-37.[Abstract]
    12. 12
  12. Giraud, A., I. Matic, O. Tenaillon, A. Clara, M. Radman, M. Fons, and F. Taddei. 2001. Costs and benefits of high mutation rates: adaptive evolution of bacteria in the mouse gut. Science 291:2606-2608.[Abstract/Free Full Text]
    13. 13
  13. Grundström, T., and B. Jaurin. 1982. Overlap between ampC and frd operons on the Escherichia coli chromosome. Proc. Natl. Acad. Sci. USA 79:1111-1115.[Abstract/Free Full Text]
    14. 14
  14. Gumbiner-Russo, L. M., M.-J. Lombardo, R. G. Ponder, and S. M. Rosenberg. 2001. The TGV transgenic vectors for single-copy gene expression from the Escherichia coli chromosome. Gene 273:97-104.[CrossRef][Medline]
    15. 15
  15. Harris, R. S., K. J. Ross, and S. M. Rosenberg. 1996. Opposing roles of the Holliday junction processing systems of Escherichia coli in recombination-dependent adaptive mutation. Genetics 142:681-691.[Abstract]
    16. 16
  16. Herrera, G., V. Aleixandra, A. Urios, and M. Blanco. 1993. Quinolone action in Escherichia coli cells carrying gyrA and gyrB mutations. FEMS Microbiol. Lett. 106:187-191.[CrossRef][Medline]
    17. 17
  17. Higgins, D. G., J. D. Thompson, and T. J. Gibson. 1996. Using CLUSTAL for multiple sequence alignments. Methods Enzymol. 266:383-402.[Medline]
    18. 18
  18. Honoré, N., M.-H. Nicolas, and S. T. Cole. 1989. Regulation of enterobacterial cephalosporinase production: the role of the membrane-bound sensory transducer. Mol. Microbiol. 3:1121-1130.[CrossRef][Medline]
    19. 19
  19. Jacobs, C., J.-M. Frère, and S. Normark. 1997. Cytosolic intermediates for cell wall biosynthesis and degradation control inducible ß-lactam resistance in gram-negative bacteria. Cell 88:823-832.[CrossRef][Medline]
    20. 20
  20. Jacobs, C., L. J. Huang, E. Bartowsky, S. Normark, and J. T. Park. 1994. Bacterial cell wall recycling provides cytosolic muropeptides as effectors for ß-lactamase induction. EMBO J. 13:4684-4694.[Medline]
    21. 21
  21. Jacobs, C., B. Joris, M. Jamin, K. Klarsov, J. Van Beeumen, D. Mengin-Lecreulx, J. van Heijenoort, J. T. Park, S. Normark, and J.-M. Frère. 1995. AmpD, essential for both ß-lactamase regulation and cell wall recycling, is a novel cytosolic N-acetylmuramyl-L-alanine amidase. Mol. Microbiol. 15:553-559.[Medline]
    22. 22
  22. Karunakaran, P., and J. Davies. 2000. Genetic antagonism and hypermutability in Mycobacterium smegmatis. J. Bacteriol. 182:3331-3335.[Abstract/Free Full Text]
    23. 23
  23. Kohler, T., M. Michea-Hamzehpour, P. Plesiat, A. L. Kahr, and J. C. Pechère. 1997. Differential selection of multidrug efflux systems by quinolones in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 41:2540-2543.[Abstract]
    24. 24
  24. Kopp, U., B. Wiedemann, S. Lindquist, and S. Normark. 1993. Sequences of wild-type and mutant ampD genes of Citrobacter freundii and Enterobacter cloacae. Antimicrob. Agents Chemother. 37:224-228.[Abstract/Free Full Text]
    25. 25
  25. Langaee, T. Y., L. Gagnon, and A. Huletsky. 2000. Inactivation of the ampD gene in Pseudomonas aeruginosa leads to moderate-basal-level and hyperinducible AmpC ß-lactamase expression. Antimicrob. Agents Chemother. 44:583-589.[Abstract/Free Full Text]
    26. 26
  26. Lea, D. E., and C. A. Coulson. 1949. The distribution of the numbers of mutants in bacterial populations. J. Genet. 49:264-285.[CrossRef]
    27. 27
  27. Lindberg, F., S. Lindquist, and S. Normark. 1987. Inactivation of the ampD gene causes semiconstitutive overproduction of the inducible Citrobacter freundii ß-lactamase. J. Bacteriol. 169:1923-1928.[Abstract/Free Full Text]
    28. 28
  28. Lindquist, S., M. Galleni, F. Lindberg, and S. Normark. 1989. Signaling proteins in enterobacterial AmpC ß-lactamase regulation. Mol. Microbiol. 3:1091-1102.[Medline]
    29. 29
  29. Little, J. W., S. H. Edmiston, L. Z. Pacelli, and D. W. Mount. 1980. Cleavage of the Escherichia coli LexA protein by the RecA protease. Proc. Natl. Acad. Sci. USA 77:3225-3229.[Abstract/Free Full Text]
    30. 30
  30. Livermore, D. M. 1995. ß-Lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8:557-584.[Abstract]
    31. 31
  31. Martinez, J. L., and F. Baquero. 2000. Mutation frequencies and antibiotic resistance. Antimicrob. Agents Chemother. 44:1771-1777.[Free Full Text]
    32. 32
  32. Maurelli, A. T., R. E. Fernández, C. A. Bloch, C. K. Rode, and A. Fasano. 1998. "Black holes" and bacterial pathogenicity: a large genomic deletion that enhances the virulence of Shigella spp. and enteroinvasive Escherichia coli. Proc. Natl. Acad. Sci. USA 95:3943-3948.[Abstract/Free Full Text]
    33. 33
  33. McKenzie, G. J., R. S. Harris, P. L. Lee, and S. M. Rosenberg. 2000. The SOS response regulates adaptive mutation. Proc. Natl. Acad. Sci. USA 97:6646-6651.[Abstract/Free Full Text]
    34. 34
  34. McKenzie, G. J., and S. M. Rosenberg. 2001. Adaptive mutations, mutator DNA polymerases and genetic change strategies of pathogens. Curr. Opin. Microbiol. 4:586-594.[CrossRef][Medline]
    35. 35
  35. Nicolas, M.-H., N. Honore, V. Jarlier, A. Philippon, and S. T. Cole. 1987. Molecular genetic analysis of cephalosporinase production and its role in ß-lactam resistance in clinical isolates of Enterobacter cloacae. Antimicrob. Agents Chemother. 31:295-299.[Abstract/Free Full Text]
    36. 36
  36. Riesenfeld, C., M. Everett, L. J. Piddock, and B. G. Hall. 1997. Adaptive mutations produce resistance to ciprofloxacin. Antimicrob. Agents Chemother. 41:2059-2060.[Abstract]
    37. 37
  37. Rosenberg, S. M. 2001. Evolving responsively: adaptive mutation. Nat. Rev. Genet. 2:504-515.[Medline]
    38. 38
  38. Sanders, C. C., and W. E. Sanders, Jr. 1992. ß-Lactam resistance in gram-negative bacteria: global trends and clinical impact. Clin. Infect. Dis. 15:824-839.[Medline]
    39. 39
  39. Stapleton, P., K. Shannon, and I. Phillips. 1995. DNA sequence differences of ampD mutants of Citrobacter freundii. Antimicrob. Agents Chemother. 39:2494-2498.[Abstract]
    40. 40
  40. Sutton, M. D., B. T. Smith, V. G. Godoy, and G. C. Walker. 2000. The SOS response: recent insights into umuDC-dependent mutagenesis and DNA damage tolerance. Annu. Rev. Genet. 34:479-497.[CrossRef][Medline]
    41. 41
  41. Taddei, F., J. A. Halliday, I. Matic, and M. Radman. 1997. Genetic analysis of mutagenesis in aging Escherichia coli colonies. Mol. Gen. Genet. 256:277-281.[CrossRef][Medline]
    42. 42
  42. Taddei, F., I. Matic, B. Godelle, and M. Radman. 1997. To be a mutator, or how pathogenic and commensal bacteria can evolve rapidly. Trends Microbiol. 5:427-428.[CrossRef][Medline]
    43. 43
  43. Taddei, F., I. Matic, and M. Radman. 1995. cAMP-dependent SOS induction and mutagenesis in resting bacterial populations. Proc. Natl. Acad. Sci. USA 92:11736-11740.[Abstract/Free Full Text]

Antimicrobial Agents and Chemotherapy, May 2002, p. 1535-1539, Vol. 46, No. 5
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.5.1535-1539.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Petrosino, J. F., Galhardo, R. S., Morales, L. D., Rosenberg, S. M. (2009). Stress-Induced {beta}-Lactam Antibiotic Resistance Mutation and Sequences of Stationary-Phase Mutations in the Escherichia coli Chromosome. J. Bacteriol. 191: 5881-5889 [Abstract] [Full Text]  
  • Kaneko, K., Okamoto, R., Nakano, R., Kawakami, S., Inoue, M. (2005). Gene Mutations Responsible for Overexpression of AmpC {beta}-Lactamase in Some Clinical Isolates of Enterobacter cloacae. J. Clin. Microbiol. 43: 2955-2958 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Petrosino, J. F.
Right arrow Articles by Rosenberg, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Petrosino, J. F.
Right arrow Articles by Rosenberg, S. M.
Right arrowPubmed/NCBI databases
*Substance via MeSH

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»